Impact of hypertriglyceridemia on endothelial dysfunction during statin ± ezetimibe therapy in patients with coronary heart disease

American Journal of Cardiology

Volumn 108, Issue 3, 2011, Pages 333-339

  Yunoki, Kei ^a   Nakamura, Kazufumi ^a   Miyoshi, Toru ^a   Enko, Kenki ^a   Kubo, Motoki ^a   Murakami, Masato ^a   Hata, Yoshiki ^a   Kohno, Kunihisa ^a   Morita, Hiroshi ^a   Kusano, Kengo F ^a   Ito, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADD ON THERAPY; ADULT; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATION; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANGIOPLASTY, BALLOON, CORONARY; AZETIDINES; CHOLESTEROL, HDL; CORONARY ARTERY BYPASS; CORONARY DISEASE; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTRIGLYCERIDEMIA; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RECURRENCE; REGRESSION ANALYSIS; TRIGLYCERIDES; VASODILATION;

EID: 79960341953     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.03.049     Document Type: Article

References (28)

1. J. Chalmers The 1999 WHO-ISH guidelines for the management of hypertension Med J Aust 171 1999 458 459
2. T. Teramoto, J. Sasaki, H. Ueshima, G. Egusa, M. Kinoshita, K. Shimamoto, H. Daida, S. Biro, K. Hirobe, T. Funahashi, K. Yokote, and M. Yokode Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese J Atheroscler Thromb 14 2007 45 50
3. M.C. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, M.A. Creager, J. Deanfield, H. Drexler, M. Gerhard-Herman, D. Herrington, P. Vallance, J. Vita, R. Vogel International Brachial Artery Reactivity Task Force Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265 (Pubitemid 34084631)
4. K.M. Mki-Petj, A.D. Booth, F.C. Hall, S.M. Wallace, J. Brown, C.M. McEniery, and I.B. Wilkinson Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis J Am Coll Cardiol 50 2007 852 858 (Pubitemid 47268750)
5. S.C. Smith Jr, J. Allen, S.N. Blair, R.O. Bonow, L.M. Brass, G.C. Fonarow, S.M. Grundy, L. Hiratzka, D. Jones, H.M. Krumholz, L. Mosca, R.C. Pasternak, T. Pearson, M.A. Pfeffer, K.A. Taubert AHA/ACC; National Heart, Lung, and Blood Institute AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 2006 2363 2372 (Pubitemid 43947981)
6. P. Lundman, M. Eriksson, K. Schenck-Gustafsson, F. Karpe, and P. Tornvall Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease Circulation 96 1997 3266 3268 (Pubitemid 27513391)
7. T.V. Lewis, A.M. Dart, and J.P. Chin-Dusting Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol J Am Coll Cardiol 33 1999 805 812
8. G.B. Schnell, A. Robertson, D. Houston, L. Malley, and T.J. Anderson Impaired brachial artery endothelial function is not predicted by elevated triglycerides J Am Coll Cardiol 33 1999 2038 2043
9. A. Alipour, A.J. van Oostrom, A. Izraeljan, C. Verseyden, J.M. Collins, K.N. Frayn, T.W. Plokker, J.W. Elte, and M.C. Cabezas Leukocyte activation by triglyceride-rich lipoproteins Arterioscler Thromb Vasc Biol 28 2008 792 797 (Pubitemid 351651339)
10. G.D. Norata, L. Grigore, S. Raselli, L. Redaelli, A. Hamsten, F. Maggi, P. Eriksson, and A.L. Catapano Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies Atherosclerosis 193 2007 321 327 (Pubitemid 47064402)
11. J.H. Bae, E. Bassenge, K.B. Kim, Y.N. Kim, K.S. Kim, H.J. Lee, K.C. Moon, M.S. Lee, K.Y. Park, and M. Schwemmer Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress Atherosclerosis 155 2001 517 523 (Pubitemid 32209324)
12. J.V. Patel, M.J. Caslake, A. Vyas, J.K. Cruickshank, D. Prabhakaran, D. Bhatnagar, K.S. Reddy, G.Y. Lip, M.I. Mackness, E.A. Hughes, and P.N. Durrington Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations Atherosclerosis 209 2010 579 584
13. D. Masuda, Y. Nakagawa-Toyama, K. Nakatani, M. Inagaki, K. Tsubakio-Yamamoto, J.C. Sandoval, T. Ohama, M. Nishida, M. Ishigami, and S. Yamashita Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia Eur J Clin Invest 39 2009 689 698
14. D. Bulut, C. Hanefeld, N. Bulut-Streich, C. Graf, A. Mgge, and M. Spiecker Endothelial function in the forearm circulation of patients with the metabolic syndromeeffect of different lipid-lowering regimens Cardiology 104 2005 176 180 (Pubitemid 41407271)
15. M. Settergren, F. Böhm, L. Rydén, and J. Pernow Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease Eur Heart J 29 2008 1753 1760 (Pubitemid 352019812)
16. J.K. Olijhoek, G.R. Hajer, Y. van der Graaf, G.M. Dallinga-Thie, and F.L. Visseren The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial J Cardiovasc Pharmacol 52 2008 145 150
17. P.E. Westerweel, F.L. Visseren, G.R. Hajer, J.K. Olijhoek, I.E. Hoefer, P. de Bree, S. Rafii, P.A. Doevendans, and M.C. Verhaar Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy Eur Heart J 29 2008 2808 2817
18. M.H. Davidson, T. MaGarry, R. Bettis, L. Melani, L.J. Lipka, A.P. LeBeaut, R. Suresh, S. Sun, and E.P. Veltri Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia J Am Coll Cardiol 40 2002 2125 2134 (Pubitemid 36005898)
19. C.M. Ballantyne, J. Houri, A. Notarbartolo, L. Melani, L.J. Lipka, R. Suresh, S. Sun, A.P. LeBeaut, P.T. Sager, E.P. Veltri Ezetimibe Study Group Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial Circulation 107 2003 2409 2415 (Pubitemid 36605221)
20. M. Miller, C.P. Cannon, S.A. Murphy, J. Qin, K.K. Ray, E. Braunwald PROVE IT-TIMI 22 Investigators Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial J Am Coll Cardiol 51 2008 724 730 (Pubitemid 351221217)
21. Y. Kitta, J.E. Obata, T. Nakamura, M. Hirano, Y. Kodama, D. Fujioka, Y. Saito, K. Kawabata, K. Sano, T. Kobayashi, T. Yano, K. Nakamura, and K. Kugiyama Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease J Am Coll Cardiol 53 2009 323 330
22. Y. Saito, N. Yamada, K. Nakatani, T. Teramoto, S. Oikawa, S. Yamashita, M. Tsushima, M. Nakashima, and A. Yamamoto Phase III clinical study of ezetimibedouble-blind comparative study with colestilan J Clin Ther Med 23 2007 493 522
23. J.R. Nofer, M. van der Giet, M. Tölle, I. Wolinska, K. von Wnuck Lipinski, H.A. Baba, U.J. Tietge, A. Gödecke, I. Ishii, B. Kleuser, M. Schfers, M. Fobker, W. Zidek, G. Assmann, J. Chun, and B. Levkau HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3 J Clin Invest 113 2004 569 581 (Pubitemid 38542506)
24. R. Noor, U. Shuaib, C.X. Wang, K. Todd, U. Ghani, B. Schwindt, and A. Shuaib High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis Atherosclerosis 192 2007 92 99 (Pubitemid 46628807)
25. A. Warnholtz, P. Wild, M.A. Ostad, V. Elsner, F. Stieber, R. Schinzel, U. Walter, D. Peetz, K. Lackner, S. Blankenberg, and K. Munzel Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study Atherosclerosis 204 2009 216 221
26. O. Hussein, L. Minasian, Y. Itzkovich, K. Shestatski, L. Solomon, and J. Zidan Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin Br J Clin Pharmacol 65 2008 637 645 (Pubitemid 351535082)
27. U. Seedorf, T. Engel, A. Lueken, G. Bode, S. Lorkowski, and G. Assmann Cholesterol absorption inhibitor Ezetimibe blocks uptake of oxidized LDL in human macrophages Biochem Biophys Res Commun 320 2004 1337 1341 (Pubitemid 38916690)
28. B.G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjaerg-Hansen Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 2007 299 308 (Pubitemid 47080484)